IGLON5 and Cognitive impairment: Initiation of immunotherapy in patients with LGI1 and IgLON5 autoantibodies can partially reverse the cognitive impairment, underscoring both, the need for and the potential of early autoantibody diagnostics in presumed neurodegenerative diseases.